1058 related articles for article (PubMed ID: 1537468)
21. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes.
Mimura M; Yamazaki H; Sugahara C; Hiroi T; Funae Y; Shimada T
Biochem Pharmacol; 1994 Jun; 47(11):1957-63. PubMed ID: 7912070
[TBL] [Abstract][Full Text] [Related]
22. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
[TBL] [Abstract][Full Text] [Related]
23. Inhibition and induction of cytochrome P450 isozymes after repetitive administration of imipramine in rats.
Masubuchi Y; Takahashii C; Fujio N; Horie T; Suzuki T; Imaoka S; Funae Y; Narimatsu S
Drug Metab Dispos; 1995 Sep; 23(9):999-1003. PubMed ID: 8565792
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of N-nitroso-2,6-dimethylmorpholine by isozymes of rabbit liver microsomal cytochrome P-450.
Kokkinakis DM; Koop DR; Scarpelli DG; Coon MJ; Hollenberg PF
Cancer Res; 1985 Feb; 45(2):619-24. PubMed ID: 3967237
[TBL] [Abstract][Full Text] [Related]
25. Studies on the rate-determining factor in testosterone hydroxylation by rat liver microsomal cytochrome P-450: evidence against cytochrome P-450 isozyme:isozyme interactions.
Dutton DR; McMillen SK; Sonderfan AJ; Thomas PE; Parkinson A
Arch Biochem Biophys; 1987 Jun; 255(2):316-28. PubMed ID: 3109324
[TBL] [Abstract][Full Text] [Related]
26. Effect of phenobarbital and other model inducers on cytochrome P450 isoenzymes in primary culture of dog hepatocytes.
Nishibe Y; Hirata M
Xenobiotica; 1993 Jun; 23(6):681-92. PubMed ID: 8212741
[TBL] [Abstract][Full Text] [Related]
27. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
Kupfer D; Mani C; Lee CA; Rifkind AB
Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
[TBL] [Abstract][Full Text] [Related]
28. Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes.
Yamazaki H; Mimura M; Oda Y; Inui Y; Shiraga T; Iwasaki K; Guengerich FP; Shimada T
Carcinogenesis; 1993 Jul; 14(7):1271-8. PubMed ID: 8330339
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the cytochrome P450 isozyme that metabolizes ochratoxin A, using metabolic inducers, inhibitors and antibodies.
Hietanen E; Bartsch H; Béréziat JC; Castegnaro M; Michelon J
IARC Sci Publ; 1991; (115):297-304. PubMed ID: 1820345
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome P-450 isozyme/isozyme functional interactions and NADPH-cytochrome P-450 reductase concentrations as factors in microsomal metabolism of warfarin.
Kaminsky LS; Guengerich FP
Eur J Biochem; 1985 Jun; 149(3):479-89. PubMed ID: 3924614
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 catalyzed metabolism of 1,2-dibromoethane in liver microsomes of differentially induced rats.
Wormhoudt LW; Ploemen JH; Commandeur JN; van Ommen B; van Bladeren P; Vermeulen NP
Chem Biol Interact; 1996 Jan; 99(1-3):41-53. PubMed ID: 8620578
[TBL] [Abstract][Full Text] [Related]
32. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
Barham HM; Lennard MS; Tucker GT
Biochem Pharmacol; 1994 Apr; 47(8):1295-307. PubMed ID: 8185638
[TBL] [Abstract][Full Text] [Related]
33. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
Miller NE; Halpert JR
Drug Metab Dispos; 1987; 15(6):846-51. PubMed ID: 2893712
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of cytochrome P450 isozymes from beta-naphthoflavone-induced adult hen liver.
Gupta RP; Lapadula DM; Abou-Donia MB
Arch Biochem Biophys; 1990 Oct; 282(1):170-82. PubMed ID: 2171427
[TBL] [Abstract][Full Text] [Related]
35. Specifically designed thiosteroids as active-site-directed probes for functional dissection of rat liver cytochrome P450 3A isozymes.
Underwood MC; Cashman JR; Correia MA
Chem Res Toxicol; 1992; 5(1):42-53. PubMed ID: 1581535
[TBL] [Abstract][Full Text] [Related]
36. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of inducers of cytochrome P450 on Mongolian gerbil and rat hepatic microsomal monooxygenase activities.
Fentem JH; Fry JR
Xenobiotica; 1991 Jul; 21(7):895-904. PubMed ID: 1776265
[TBL] [Abstract][Full Text] [Related]
38. Metabolic activation of lidocaine and covalent binding to rat liver microsomal protein.
Masubuchi Y; Araki J; Narimatsu S; Suzuki T
Biochem Pharmacol; 1992 Jun; 43(12):2551-7. PubMed ID: 1632813
[TBL] [Abstract][Full Text] [Related]
39. 1-Ethynylpyrene, a suicide inhibitor of cytochrome P-450 dependent benzo[a]pyrene hydroxylase activity in liver microsomes.
Gan LS; Acebo AL; Alworth WL
Biochemistry; 1984 Aug; 23(17):3827-36. PubMed ID: 6487578
[TBL] [Abstract][Full Text] [Related]
40. Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats.
Murray M
Arch Biochem Biophys; 1988 May; 262(2):381-8. PubMed ID: 3364973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
